Obesity rates in renal stone formers from various countries.


Journal

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
ISSN: 2282-4197
Titre abrégé: Arch Ital Urol Androl
Pays: Italy
ID NLM: 9308247

Informations de publication

Date de publication:
30 Jun 2021
Historique:
received: 28 06 2021
entrez: 21 7 2021
pubmed: 22 7 2021
medline: 26 11 2021
Statut: epublish

Résumé

To collect evidence on the rate of obesity in renal stone formers (RSFs) living in different climatic areas and consuming different diets. Data of adult renal stone formers were retrospectively collected by members of U-merge from 13 participant centers in Argentina, Brazil, Bulgaria (2), China, India, Iraq (2), Italy (2), Nigeria, Pakistan and Poland. The following data were collected: age, gender, weight, height, stone analysis and procedure of stone removal. In total, 1689 renal stone formers (1032 males, 657 females) from 10 countries were considered. Average age was 48 (±14) years, male to female ratio was 1.57 (M/F 1032/657), the average body mass index (BMI) was 26.5 (±4.8) kg/m2. The obesity rates of RSFs in different countries were significantly different from each other. The highest rates were observed in Pakistan (50%), Iraq (32%), and Brazil (32%), while the lowest rates were observed in China (2%), Nigeria (3%) and Italy (10%). Intermediate rates were observed in Argentina (17%), Bulgaria (17%), India (15%) and Poland (22%). The age-adjusted obesity rate of RSFs was higher than the age-adjusted obesity rate in the general population in Brazil, India, and Pakistan, whereas it was lower in Argentina, Bulgaria, China, Italy, and Nigeria, and similar in Iraq and Poland. The age-adjusted obesity rate of RSFs was not higher than the age-adjusted obesity rate of the general population in most countries. The relationship between obesity and the risk of kidney stone formation should be reconsidered by further studies carried out in different populations.

Identifiants

pubmed: 34286554
doi: 10.4081/aiua.2021.2.189
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-194

Auteurs

Elenko Popov (E)

U-merge Ltd. (Urology for emerging countries), London, UK; Acibadem City Clinic Tokuda Hospital, Sofia. noor.buchholz@gmail.com.

Murtadha Almusafer (M)

U-merge Ltd. (Urology for emerging countries), London, UK; College of Medicine, University of Basrah, Basrah. noor.buchholz@gmail.com.

Arben Belba (A)

U-merge Ltd. (Urology for emerging countries), London, UK; Ospedale Santo Stefano, Prato and Casa di Cura Villa Donatello, Sesto Fiorentino. noor.buchholz@gmail.com.

Jibril O Bello (JO)

U-merge Ltd. (Urology for emerging countries), London, UK; Department of Surgery, Urology Unit, University of Ilorin Teaching Hospital. noor.buchholz@gmail.com.

Kamran Hassan Bhatti (KH)

U-merge Ltd. (Urology for emerging countries), London, UK; Urology Department, Hamad Medical Corporation, Doha. noor.buchholz@gmail.com.

Luca Boeri (L)

U-merge Ltd. (Urology for emerging countries), London, UK; Department of Urology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan. noor.buchholz@gmail.com.

Kaloyan Davidoff (K)

U-merge Ltd. (Urology for emerging countries), London, UK; Acibadem City Clinic Tokuda Hospital, Sofia. noor.buchholz@gmail.com.

Bm Zeeshan Hameed (BZ)

U-merge Ltd. (Urology for emerging countries), London, UK; Department of Urology, Kasturba Medical College, Manipal, Karnataka. noor.buchholz@gmail.com.

Adam Halinski (A)

U-merge Ltd. (Urology for emerging countries), London, UK; Private Medical Center "Klinika Wisniowa" Zielona Gora. noor.buchholz@gmail.com.

Ita Pfeferman Heilberg (I)

U-merge Ltd. (Urology for emerging countries), London, UK; Nephrology Division, Universidade Federal de São Paulo (UNIFESP), São Paulo. noor.buchholz@gmail.com.

Hongyi Hui (H)

U-merge Ltd. (Urology for emerging countries), London, UK; Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai. noor.buchholz@gmail.com.

Kremena Petkova (K)

U-merge Ltd. (Urology for emerging countries), London, UK; Department of Urology and Nephrology, Military Medical Academy, Sofia. noor.buchholz@gmail.com.

Bapir Rawa (B)

U-merge Ltd. (Urology for emerging countries), London, UK; Smart Health Tower, Sulaymaniyah, Kurdistan region. noor.buchholz@gmail.com.

Fernanda Guedes Rodrigues (F)

U-merge Ltd. (Urology for emerging countries), London, UK; Nephrology Division, Universidade Federal de São Paulo (UNIFESP), São Paulo. noor.buchholz@gmail.com.

Iliya Saltirov (I)

U-merge Ltd. (Urology for emerging countries), London, UK; Department of Urology and Nephrology, Military Medical Academy, Sofia. noor.buchholz@gmail.com.

Francisco R Spivacow (FR)

U-merge Ltd. (Urology for emerging countries), London, UK; Instituto de Investigaciones Metabólicas (IDIM), Buenos Aires. noor.buchholz@gmail.com.

Alberto Trinchieri (A)

U-merge Ltd. (Urology for emerging countries), London. noor.buchholz@gmail.com.

Noor Buchholz (N)

U-merge Ltd. (Urology for emerging countries), London. noor.buchholz@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH